Illumina Inc. Receives Order for 75th Genome Analyzer.
Illumina Inc. announced that it has now received more than 75 orders for the Genome Analyzer, the Company's DNA sequencing, gene expression profiling, and micro-RNA analysis platform. In addition to the Broad Institute, which has already installed 16 Genome Analyzers out of a near term goal of 20, demand for the sequencing system has increased significantly among genome centers, core laboratories, industrial laboratories, and individual academic centers worldwide.
